Clinical Trial – Treating Constipation in MS – Constipation

The investigators seek to test whether incorporating the scheduled dosing of a bisacodyl 10 mg rectal suppository every other day improves bowel-related symptoms in patients with multiple sclerosis. Patients will be randomized to receive either a placebo suppository or bisacodyl suppository dosed every other day for 4 weeks.

Study Type  : Interventional  (Clinical Trial)
Estimated Enrollment  : 70 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Treatment
Official Title: Treating Anorectal Dysfunction Associated With Multiple Sclerosis
Study Start Date  : June 2016
Estimated Primary Completion Date  : December 2019
Estimated Study Completion Date  : April 2020
Contacts

David J Levinthal, MD, PhD            412-303-0525          levinthald@upmc.edu 

ClinicalTrials.gov Identifier: NCT02609607

For enrollment please visit   www.clinicaltrials.gov.

* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.